• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2型糖尿病的感知风险:利用关联的基因组、临床和问卷调查数据来了解基因风险工具在英国南亚人群中的潜在用途。

Perceived risk of type 2 diabetes: Using linked genomic, clinical and questionnaire data to understand the potential use of genetic risk tools in British South Asians.

作者信息

Law Jing Hui, Stow Daniel, Hodgson Sam, van Heel David A, Newman William G, Osman Magda, Finer Sarah

机构信息

Wolfson Institute of Population Health, Queen Mary University of London, London, United Kingdom.

Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom.

出版信息

PLOS Glob Public Health. 2025 Mar 31;5(3):e0004274. doi: 10.1371/journal.pgph.0004274. eCollection 2025.

DOI:10.1371/journal.pgph.0004274
PMID:40163504
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11957276/
Abstract

Despite growing interest surrounding the integration of genetic risk tools such as polygenic risk scores (PRSs) into routine care for early disease identification and management, major questions remain about whether and how these tools are to be implemented at-scale. Many interventions have explored their use in encouraging the adoption of preventative health behaviours-yet existing evidence remains undetermined, limited by the focus on White European populations. The present study used structural equation modelling to explore genetic risk perceptions surrounding type 2 diabetes (T2D) in a sample of British Bangladeshi and British Pakistani volunteers-combining questionnaire data alongside genomic and clinical information to identify the characteristics of individuals who are likely to act on genetic risk information. We conducted this study with volunteers enrolled in Genes & Health-a large-scale (n > 60,000) study in the UK recruiting British Bangladeshi and British Pakistani volunteers from community and NHS settings. Eligible participants between the ages of 16 to 59 years were invited to complete a 15-minute questionnaire containing measures of genetic risk perceptions surrounding T2D, as well as intention to adopt health behaviours and that can prevent or delay T2D. Questionnaire responses were then integrated with participants' genomic and clinical data available at Genes & Health to construct a model-characterising their mediating relationships in informing participants' intention. A total of 626 participants responded to the questionnaire (response rate = 17%, 37.70% aged 46 to 59 years, 62.62% female). Being between the ages of 46 to 59 years (β = 0.52, 95% CI [0.26, 0.79], p < 0.05), having greater self-reported perceived control over health (β = 0.41, 95% CI [0.26, 0.56], p < 0.05) and interest in genetic testing (β = 0.62, 95% CI [0.46, 0.78], p < 0.05) all had direct positive effects on participants' intention. Household income showed an indirect effect on intention, mediated by interest in genetic testing, β = 0.24, 95% CI [0.12, 0.37]. Self-identified ethnicity also demonstrated indirect effects on intention via two mediating pathways-both involving participants' T2D PRSs and self-reported family history of T2D (β = 0.03, 95% CI [0.02, 0.05] and β = 0.002, 95% CI [0.001, 0.01]). Our results showed that older age, greater perceived control over health and interest in genetic testing are all predictive of participants' likelihood of adopting preventative heath behaviours in response to genetic risk information about T2D. We also found evidence pointing to the roles that wider socio-demographic, clinical and familial variables can play in informing and mediating genetic risk perceptions. These findings should raise awareness about potential challenges to the equitable delivery and management of genetic risk tools-and strengthen calls for wider family- and system-level approaches that can help address potential health inequalities, as efforts surrounding the large-scale implementation of genomics into existing health systems continue to grow.

摘要

尽管围绕将多基因风险评分(PRSs)等遗传风险工具整合到疾病早期识别和管理的常规护理中,人们的兴趣日益浓厚,但关于这些工具是否以及如何大规模实施,仍存在重大问题。许多干预措施都在探索其在鼓励采取预防性健康行为方面的应用——然而,现有证据仍不明确,这受到对欧洲白人人群关注的限制。本研究使用结构方程模型,在英国孟加拉裔和巴基斯坦裔志愿者样本中探索围绕2型糖尿病(T2D)的遗传风险认知——将问卷数据与基因组和临床信息相结合,以确定可能根据遗传风险信息采取行动的个体特征。我们对参与“基因与健康”项目的志愿者进行了这项研究,该项目是英国一项大规模(n>60,000)的研究,从社区和国民保健服务机构招募英国孟加拉裔和巴基斯坦裔志愿者。邀请年龄在16至59岁之间的符合条件的参与者完成一份15分钟的问卷,其中包含对围绕T2D的遗传风险认知的测量,以及采取可预防或延缓T2D的健康行为的意愿。然后,将问卷回答与参与者在“基因与健康”项目中可获得的基因组和临床数据相结合,构建一个模型,描述它们在影响参与者意愿方面的中介关系。共有626名参与者回复了问卷(回复率=17%,46至59岁的占37.70%,女性占62.62%)。年龄在46至59岁之间(β=0.52,95%可信区间[0.26,0.79],p<0.05)、自我报告对健康有更大的感知控制(β=0.41,95%可信区间[0.26,0.56],p<0.05)以及对基因检测感兴趣(β=0.62,95%可信区间[0.46,0.7],p<0.05)都对参与者的意愿有直接的积极影响。家庭收入通过对基因检测的兴趣产生间接影响,β=0.24,95%可信区间[0.12,0.37]。自我认定的种族也通过两条中介途径对意愿产生间接影响——两者都涉及参与者的T2D PRSs和自我报告的T2D家族史(β=0.03,95%可信区间[0.02,0.05]和β=0.002,95%可信区间[0.001,0.01])。我们的结果表明,年龄较大、对健康有更大的感知控制以及对基因检测感兴趣,都预示着参与者根据关于T2D的遗传风险信息采取预防性健康行为的可能性。我们还发现证据表明,更广泛的社会人口学、临床和家庭变量在影响和中介遗传风险认知方面可以发挥作用。这些发现应该提高人们对遗传风险工具公平提供和管理潜在挑战的认识,并加强对更广泛的家庭和系统层面方法的呼吁,这些方法有助于解决潜在的健康不平等问题,因为将基因组学大规模应用于现有卫生系统的努力仍在不断增加。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c143/11957276/1dddf58cacdf/pgph.0004274.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c143/11957276/e5666a07f961/pgph.0004274.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c143/11957276/51c57e2c26a6/pgph.0004274.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c143/11957276/f808e3bc3708/pgph.0004274.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c143/11957276/1dddf58cacdf/pgph.0004274.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c143/11957276/e5666a07f961/pgph.0004274.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c143/11957276/51c57e2c26a6/pgph.0004274.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c143/11957276/f808e3bc3708/pgph.0004274.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c143/11957276/1dddf58cacdf/pgph.0004274.g004.jpg

相似文献

1
Perceived risk of type 2 diabetes: Using linked genomic, clinical and questionnaire data to understand the potential use of genetic risk tools in British South Asians.2型糖尿病的感知风险:利用关联的基因组、临床和问卷调查数据来了解基因风险工具在英国南亚人群中的潜在用途。
PLOS Glob Public Health. 2025 Mar 31;5(3):e0004274. doi: 10.1371/journal.pgph.0004274. eCollection 2025.
2
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
3
Integrating polygenic risk scores in the prediction of type 2 diabetes risk and subtypes in British Pakistanis and Bangladeshis: A population-based cohort study.将多基因风险评分整合到英国巴基斯坦裔和孟加拉裔 2 型糖尿病风险和亚型的预测中:一项基于人群的队列研究。
PLoS Med. 2022 May 19;19(5):e1003981. doi: 10.1371/journal.pmed.1003981. eCollection 2022 May.
4
British South Asian Patients' Perspectives on the Relevance and Acceptability of Mobile Health Text Messaging to Support Medication Adherence for Type 2 Diabetes: Qualitative Study.英国南亚患者对移动健康短信支持 2 型糖尿病药物依从性的相关性和可接受性的看法:定性研究。
JMIR Mhealth Uhealth. 2020 Apr 20;8(4):e15789. doi: 10.2196/15789.
5
Recovery schools for improving behavioral and academic outcomes among students in recovery from substance use disorders: a systematic review.改善物质使用障碍康复期学生行为和学业成果的康复学校:一项系统综述
Campbell Syst Rev. 2018 Oct 4;14(1):1-86. doi: 10.4073/csr.2018.9. eCollection 2018.
6
Genetic basis of early onset and progression of type 2 diabetes in South Asians.南亚人2型糖尿病早发及进展的遗传基础。
Nat Med. 2025 Jan;31(1):323-331. doi: 10.1038/s41591-024-03317-8. Epub 2024 Nov 26.
7
Investigating misclassification of type 1 diabetes in a population-based cohort of British Pakistanis and Bangladeshis using polygenic risk scores.利用多基因风险评分调查英国巴基斯坦裔和孟加拉裔人群队列中1型糖尿病的错误分类情况。
Sci Rep. 2025 Jan 13;15(1):1168. doi: 10.1038/s41598-024-80348-8.
8
The effect of framing and communicating COVID-19 vaccine side-effect risks on vaccine intentions for adults in the UK and the USA: A structured summary of a study protocol for a randomized controlled trial.在英国和美国,针对成年人的 COVID-19 疫苗副作用风险的描述和沟通对疫苗接种意愿的影响:一项随机对照试验研究方案的结构化总结。
Trials. 2021 Sep 6;22(1):592. doi: 10.1186/s13063-021-05484-2.
9
Advancing the communication of genetic risk for cardiometabolic diseases: a critical interpretive synthesis.推进心血管代谢疾病遗传风险的交流:批判性综合解读。
BMC Med. 2023 Nov 13;21(1):432. doi: 10.1186/s12916-023-03150-9.
10
Impact of summer programmes on the outcomes of disadvantaged or 'at risk' young people: A systematic review.暑期项目对处境不利或“有风险”的年轻人的影响:一项系统综述。
Campbell Syst Rev. 2024 Jun 13;20(2):e1406. doi: 10.1002/cl2.1406. eCollection 2024 Jun.

本文引用的文献

1
Investigating misclassification of type 1 diabetes in a population-based cohort of British Pakistanis and Bangladeshis using polygenic risk scores.利用多基因风险评分调查英国巴基斯坦裔和孟加拉裔人群队列中1型糖尿病的错误分类情况。
Sci Rep. 2025 Jan 13;15(1):1168. doi: 10.1038/s41598-024-80348-8.
2
A unified framework for estimating country-specific cumulative incidence for 18 diseases stratified by polygenic risk.一种用于估计按多基因风险分层的 18 种疾病的特定国家累积发病率的统一框架。
Nat Commun. 2024 Jun 12;15(1):5007. doi: 10.1038/s41467-024-48938-2.
3
Advancing the communication of genetic risk for cardiometabolic diseases: a critical interpretive synthesis.
推进心血管代谢疾病遗传风险的交流:批判性综合解读。
BMC Med. 2023 Nov 13;21(1):432. doi: 10.1186/s12916-023-03150-9.
4
Systematic comparison of family history and polygenic risk across 24 common diseases.24 种常见疾病的家族史和多基因风险的系统比较。
Am J Hum Genet. 2022 Dec 1;109(12):2152-2162. doi: 10.1016/j.ajhg.2022.10.009. Epub 2022 Nov 7.
5
Recontacting biobank participants to collect lifestyle, behavioural and cognitive information via online questionnaires: lessons from a pilot study within FinnGen.通过在线问卷重新联系生物银行参与者以收集生活方式、行为和认知信息:来自 FinnGen 内试点研究的经验教训。
BMJ Open. 2022 Oct 5;12(10):e064695. doi: 10.1136/bmjopen-2022-064695.
6
Integrating polygenic risk scores in the prediction of type 2 diabetes risk and subtypes in British Pakistanis and Bangladeshis: A population-based cohort study.将多基因风险评分整合到英国巴基斯坦裔和孟加拉裔 2 型糖尿病风险和亚型的预测中:一项基于人群的队列研究。
PLoS Med. 2022 May 19;19(5):e1003981. doi: 10.1371/journal.pmed.1003981. eCollection 2022 May.
7
The Polygenic Score Catalog as an open database for reproducibility and systematic evaluation.多基因风险评分目录作为一个开放的数据库,用于可重复性和系统评估。
Nat Genet. 2021 Apr;53(4):420-425. doi: 10.1038/s41588-021-00783-5.
8
Integrated Polygenic Tool Substantially Enhances Coronary Artery Disease Prediction.综合多基因工具可显著提高冠状动脉疾病预测能力。
Circ Genom Precis Med. 2021 Apr;14(2):e003304. doi: 10.1161/CIRCGEN.120.003304. Epub 2021 Mar 2.
9
Polygenic risk scores: from research tools to clinical instruments.多基因风险评分:从研究工具到临床工具。
Genome Med. 2020 May 18;12(1):44. doi: 10.1186/s13073-020-00742-5.
10
Polygenic and clinical risk scores and their impact on age at onset and prediction of cardiometabolic diseases and common cancers.多基因和临床风险评分及其对发病年龄和心血管代谢疾病及常见癌症预测的影响。
Nat Med. 2020 Apr;26(4):549-557. doi: 10.1038/s41591-020-0800-0. Epub 2020 Apr 7.